VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SLNSilence Therapeutics plc
$10.58$500M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSLNQuarterly Financials

Silence Therapeutics plc (SLN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Silence Therapeutics plc (SLN) quarterly income statement — complete revenue, gross profit & net income history

SLN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue421.29K34K159K224K142K24.33M1.14M598K15.7M2.1M2.8M9.1M11.37M4.76M3.37M3.64M5.72M3.41M3.16M2.7M
Revenue Growth %196.68%-99.86%-86.08%-62.54%-99.1%1059.02%-59.19%-93.43%38.03%-55.95%-17%149.9%98.78%39.57%6.81%34.88%82%45.59%-371.38%
Cost of Goods Sold116.8K12K64K85K54K1.61M2.77M2.64M2.8M1.35M1.61M2.83M4.53M3.86M2.39M2.35M2.27M2.04M2.05M1.82M
COGS % of Revenue27.73%35.29%40.25%37.95%38.03%6.6%242.91%441.14%17.84%64.13%57.43%31.1%39.86%80.99%71.02%64.56%39.76%59.81%65.02%67.57%
Gross Profit304.49K22K95K139K88K22.72M-1.63M-2.04M12.9M753K1.19M6.27M6.84M906K977K1.29M3.45M1.37M1.1M876K
Gross Margin %72.27%64.71%59.75%62.05%61.97%93.4%-142.91%-341.14%82.16%35.87%42.57%68.9%60.14%19.01%28.98%35.44%60.24%40.19%34.98%32.43%
Gross Profit Growth %246.01%-99.9%105.82%106.81%-99.32%2917.47%-237.03%-132.52%88.58%-16.89%21.9%385.9%98.43%-33.97%-11.5%47.37%114.5%50.11%-52.88%
Operating Expenses15.33M12.48M26.34M24.1M28.5M25.8M20.91M16.28M18.48M14.05M13.89M17.73M18.99M11.87M14.6M15.38M13.37M12.63M13.39M13.8M
OpEx % of Revenue3637.68%36714.71%16565.41%10759.82%20068.31%106.05%1830.56%2722.91%117.71%669.46%496.43%194.75%166.95%249.05%433.05%422.18%233.64%370.09%424.21%511.03%
Selling, General & Admin7.03M3.73M5.79M5.13M7.68M5.4M5.6M5.29M6.63M4.12M4.96M5.12M6.45M3.47M5.83M4.55M5.77M5.41M5.47M5.38M
SG&A % of Revenue1667.73%10982.35%3644.65%2290.63%5411.27%22.18%490.37%884.28%42.26%196.05%177.13%56.18%56.71%72.78%172.86%124.84%100.77%158.49%173.38%199.07%
Research & Development8.34M8.75M20.54M17.65M20.81M20.4M15.3M10.99M11.85M9.94M8.93M12.62M12.54M8.4M8.77M10.83M7.6M7.22M7.92M8.17M
R&D % of Revenue1980.81%25732.35%12920.75%7878.13%14657.04%83.87%1340.19%1838.63%75.45%473.42%319.3%138.57%110.24%176.26%260.19%297.34%132.87%211.6%250.82%302.37%
Other Operating Expenses-45.72K001000K000000000000000259K
Operating Income-15.02M-12.46M-26.24M-23.96M-28.41M-3.08M-22.54M-18.32M-5.58M-13.3M-12.7M-11.46M-12.15M-10.96M-13.62M-14.09M-9.92M-11.26M-12.28M-12.93M
Operating Margin %-3565.41%-36650%-16505.66%-10697.77%-20006.34%-12.65%-1973.47%-3064.05%-35.55%-633.59%-453.86%-125.85%-106.81%-230.03%-404.06%-386.74%-173.4%-329.91%-389.23%-478.6%
Operating Income Growth %47.13%-304.79%-16.45%-30.78%-409.03%76.85%-77.47%-59.93%54.06%-21.33%6.77%18.68%-22.45%2.68%-10.88%-8.99%-6.22%6.81%--82.16%
EBITDA-14.91M-12.35M-26.09M-23.82M-28.27M-2.96M-22.42M-18.2M-5.43M-13.18M-12.57M-11.34M-12.02M-10.82M-13.51M-13.97M-9.81M-11.2M-12.17M-12.8M
EBITDA Margin %-3540.29%-36317.65%-16407.55%-10631.7%-19909.15%-12.16%-1963.4%-3044.15%-34.58%-627.82%-449.39%-124.55%-105.64%-227.07%-400.68%-383.61%-171.43%-327.97%-385.74%-474.05%
EBITDA Growth %47.24%-317.29%-16.35%-30.82%-420.74%77.55%-78.32%-60.54%54.81%-21.79%6.91%18.86%-22.49%3.37%-10.95%-9.15%-6.47%7.35%--83.19%
D&A (Non-Cash Add-back)105.82K113K156K148K138K119.28K115K119K152K121K125K118K134K141K114K114K113K66K110K123K
EBIT-15.02M-12.46M-20.96M-22.64M-28.41M7.07M-21.56M-17.26M-3.09M-15.03M-10.65M-11.12M-11.81M-15.04M-9.29M-13.42M-9.57M-11.3M-11.99M-12.71M
Net Interest Income0000012.43M-7.62M882K791K-928K2.04M-553K-524K10K4.29M669K350K2K232K219K
Interest Income00000886.95K981K1.06M804K02.05M340K336K10K4.33M669K350K2K296K219K
Interest Expense00000-11.54M8.6M183K13K928K8K893K860K034K00064K0
Other Income/Expense88.85K691K5.29M-3.38M-121K26.81M-7.62M882K3.51M-1.67M2.04M-553K-524K-4.09M4.29M669K350K36K232K219K
Pretax Income-14.93M-11.77M-20.96M-27.34M-28.53M23.74M-30.16M-17.44M-2.07M-14.97M-10.66M-12.01M-12.67M-15.05M-9.33M-13.42M-9.57M-11.23M-12.05M-12.71M
Pretax Margin %-3544.32%-34617.65%-13180.5%-12207.14%-20091.55%97.57%-2640.81%-2916.56%-13.17%-713.01%-381.02%-131.92%-111.42%-315.84%-276.65%-368.38%-167.28%-328.85%-381.88%-470.49%
Income Tax001K10K09.56M-3.15M-1.88M244K-554K-2.41M-1.61M-2.47M-1.29M-2.22M-1.48M-1.89M-1.79M-2.12M-1.08M
Effective Tax Rate %0%0%-0%-0.04%0%40.28%10.43%10.77%-11.8%3.7%22.62%13.4%19.48%8.55%23.84%11.04%19.72%15.97%17.62%8.5%
Net Income-14.93M-11.77M-20.96M-27.35M-28.53M14.17M-27.01M-15.56M-2.31M-14.41M-8.25M-10.4M-10.2M-13.76M-7.1M-11.94M-7.68M-9.43M-9.93M-11.63M
Net Margin %-3544.32%-34617.65%-13181.13%-12211.61%-20091.55%58.26%-2365.32%-2602.34%-14.73%-686.61%-294.85%-114.25%-89.71%-288.84%-210.71%-327.72%-134.29%-276.33%-314.61%-430.51%
Net Income Growth %47.66%-183.04%22.41%-75.77%-1134%198.35%-227.42%-49.62%77.34%-4.72%-16.15%12.88%-32.8%-45.89%28.46%-2.67%8.74%24.16%--110.86%
Net Income (Continuing)-14.93M-11.77M-20.96M-27.35M-28.53M14.17M-27.01M-15.56M-2.31M-14.41M-8.25M-10.4M-10.2M-13.76M-7.1M-11.94M-7.68M-9.43M-9.93M-11.63M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.33-0.27-1.32-1.74-1.800.90-1.71-0.99-0.16-1.08-0.66-0.87-0.84-1.14-0.66-1.20-0.78-0.33-0.33-0.39
EPS Growth %81.67%-130%22.81%-75.76%-1025%183.33%-159.09%-13.79%80.95%5.26%0%27.5%-7.69%-245.45%-100%-207.69%-168.97%21.43%--85.71%
EPS (Basic)-0.33-0.27-1.32-1.74-1.800.90-1.71-0.99-0.16-1.08-0.66-0.87-0.84-1.14-0.66-1.20-0.78-0.33-0.33-0.39
Diluted Shares Outstanding47.23M47.23M15.74M15.74M15.74M15.55M15.69M15.58M14.65M13.21M12.44M12.05M11.99M11.98M10.97M9.98M9.98M29.65M29.91M29.89M
Basic Shares Outstanding47.23M47.23M15.74M15.74M15.74M15.55M15.69M15.58M14.65M13.21M12.44M12.05M11.99M11.98M10.97M9.98M9.98M29.65M29.91M29.89M
Dividend Payout Ratio--------------------